Press release from Companies

Published: 2025-05-07 07:35:00

Eevia Health Plc: Eevia Health Secures KSEK 638 Order from U.S. Partner

Eevia Health Plc ("Eevia" or "the Company") has received a new sales order valued at approximately KEUR 58 (KSEK 638) from Select Ingredients, a leading U.S.-based supplier of organic ingredients and natural plant extracts.

The order is for Eevia’s lower-concentration elderberry extract, FENO-SAMBUCUS™ 7 ORGANIC. Select Ingredients, headquartered in San Diego, serves some of the most recognized health and wellness brands in California and across the United States.


The order was originally expected later this summer but was accelerated due to higher-than-anticipated consumption by the end customer—an established U.S. nutraceutical brand. With the product already in inventory, Eevia can provide immediate fulfilment, supporting both timely delivery and positive near-term cash flow impact.

The elderberry extract is associated with immune support and general wellness. Eevia’s certified organic production and Nordic sourcing make it an attractive alternative for premium health product manufacturers.

 

We see tariff effects converting into market traction and growing demand for our high-quality organic extracts,” said Erik Eide, Commercial Director of Eevia Health.

 

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: stein.ulve@eeviahealth.com                      

Telephone: +358 400 22 5967                         

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses global health challenges with bioactive compounds sustainably extracted from renewable plant materials. It focuses on the gut and related health, including kidney and urinary health.

Eevia Health is a manufacturer of 100% organically certified plant extracts. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.

As a pioneering company, Eevia is developing biomaterials that may dramatically impact human health. Eevia Health operates a modern green-chemistry production facility in Finland with a short value chain and environmentally friendly carbon footprint. Eevia listed its shares at the Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.

Läs mer hos Cision
Read more about Eevia Health Plc